Forty patients with high axSpA activity ( Bath Ankylosing Disease Activity Index ( BASDAI 4 ) were examined and randomized to 2 groups : 1 ) 30 patients who received ET 90 mg continuously every day ; 2 ) 10 patients who took the drug in the same dose intermittently 1-3 times weekly .